Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Dentin surface protein interaction" refers broadly to the interactions between non-collagenous proteins of the dentin extracellular matrix—including, but not limited to, dentin sialophosphoprotein (DSPP; processed into dentin sialoprotein (DSP), dentin phosphoprotein (DPP), and dentin glycoprotein), dentin matrix protein 1 (DMP1), bone sialoprotein (BSP), and osteopontin (OPN)—with the mineral phase (hydroxyapatite) and with cellular receptors[3][4][5][6][7]. These interactions mediate mineralization of dentin, regulate the conversion of predentin to mineralized dentin, and can participate in signaling via cell surface receptors such as integrins (e.g., DMP1–α_vβ_3 and DSP–β_6)[2][5]. The process is essential for normal tooth development and biomineralization; mutations or dysregulation in the key proteins can result in defective dentin or bone mineralization[4][8].\n\nIf you wish to refer to individual protein targets involved in this process, the most well-characterized are:\n- Dentin phosphoprotein (DPP, also known as phosphophoryn)\n- Dentin sialoprotein (DSP)\n- Dentin matrix protein 1 (DMP1)\nEach is a specific, canonical target with distinct biological function and disease association[2][5].\n\nSummary:\n"Dentin surface protein interaction" is not a single therapeutic target but rather a term describing the interactions of multiple well-characterized matrix proteins at the dentin mineral interface; as such, it is not a suitable entry for target-centric drug databases. For data structuring, map to specific matrix proteins involved when higher specificity is required.
Not applicable; MOA would be protein–mineral or protein–receptor binding leading to matrix mineralization or signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dentin surface protein interaction.